20-Year study of rare childhood brain tumors aims to spot which turn dangerous
NCT ID NCT03115164
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviewed medical records of 37 children under 18 diagnosed with rare brain tumors called DIA or DIG between 1996 and 2015 in French cancer centers. Researchers wanted to find out why some of these usually benign tumors become malignant. By analyzing clinical, genetic, and imaging data, they hope to better understand which tumors need more aggressive treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study succeeds, it could help doctors better predict which DIA/DIG tumors will become aggressive, guiding treatment decisions.
- What could go wrong
- This is a small, retrospective review of past cases, not a treatment trial. It cannot prove new therapies or change outcomes directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTROCYTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Picardie
Amiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a virus injected into brain tumors fight recurrence?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- AI reads MRI scans to spot a deadly brain tumor type without surgery
- AI reads MRI scans to spot brain tumors without surgery
- Brain tumor study probes how income and community shape health
- New hope for young brain cancer patients: targeted drug combo enters phase 2 trial